文献速递精神分裂症与精神病性障碍

精神分裂症患者初级听皮层突触蛋白质组改变

Synaptic Proteome Alterations in the Primary Auditory Cortex of Individuals With Schizophrenia.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

该配对病例对照研究纳入48例精神分裂症患者和48名对照,采用靶向质谱测量初级听皮层灰质匀浆和突触体制备中的蛋白质水平。发现突触体中经典线粒体和突触后蛋白水平显著改变,且高度共调控,不能由死后间隔、抗精神病药治疗、突触体产量或匀浆蛋白水平解释。

要点

  • 精神分裂症患者初级听皮层突触体中线粒体和突触后蛋白水平显著改变。
  • 这些改变高度共调控,不能由死后间隔、抗精神病药治疗或匀浆蛋白水平解释。
  • 结果提示突触蛋白质组存在稳健且高度协调的重排,与遗传学发现一致。

核心结论

  • 精神分裂症患者初级听皮层突触蛋白质组存在稳健且高度协调的重排。
  • 突触后蛋白水平改变与 unbiased 遗传学发现一致,为识别受损细胞和环路提供路线图。

研究设计与样本

  • 配对病例对照研究,纳入48例精神分裂症患者和48名对照,按性别、年龄和死后间隔匹配。
  • 采用靶向质谱测量初级听皮层灰质匀浆和突触体制备中的蛋白质水平,实验者设盲。

主要发现

  • 突触体中经典线粒体和突触后蛋白水平出现稳健改变(调整 Limma P < .05)。
  • 这些改变高度共调控,且不能由死后间隔、抗精神病药治疗、突触体产量或匀浆蛋白水平解释。

关键数值与推荐

  • 统计 cutoff 设为调整 Limma P < .05。
  • 两组平均年龄均为48岁(范围17-83岁),每组35名男性(73%)和13名女性(27%)。

临床怎么用

  • 提示初级听皮层突触后蛋白和线粒体蛋白改变可能是精神分裂症病理生理的重要环节。
  • 为未来针对特定细胞和环路的突触蛋白研究提供候选靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Findings from unbiased genetic studies have consistently implicated synaptic protein networks in schizophrenia, but the molecular pathologic features within these networks and their contribution to the synaptic and circuit deficits thought to underlie disease symptoms remain unknown. OBJECTIVE: To determine whether protein levels are altered within synapses from the primary auditory cortex (A1) of individuals with schizophrenia and, if so, whether these differences are restricted to the synapse or occur throughout the gray matter. DESIGN, SETTING, AND PARTICIPANTS: This paired case-control study included tissue samples from individuals with schizophrenia obtained from the Allegheny County Office of the Medical Examiner. An independent panel of health care professionals made consensus DSM-IV diagnoses. Each tissue sample from an individual with schizophrenia was matched by sex, age, and postmortem interval with 1 sample from an unaffected control individual. Targeted mass spectrometry was used to measure protein levels in A1 gray matter homogenate and synaptosome preparations. All experimenters were blinded to diagnosis. Mass spectrometry data were collected from September 26 through November 4, 2016, and analyzed from November 3, 2016, to July 15, 2019. MAIN OUTCOMES AND MEASURES: Primary measures were homogenate and synaptosome protein levels and their coregulation network features. Hypotheses generated before data collection were (1) that levels of canonical postsynaptic proteins in A1 synaptosome preparations would differ between individuals with schizophrenia and controls and (2) that these differences would not be explained by changes in total A1 homogenate protein levels. RESULTS: Synaptosome and homogenate protein levels were investigated in 48 individuals with a schizophrenia diagnosis and 48 controls (mean age in both groups, 48 years [range, 17-83 years]); each group included 35 males (73%) and 13 females (27%). Robust alterations (statistical cutoff set at an adjusted Limma P < .05) were observed in synaptosome levels of canonical mitochondrial and postsynaptic proteins that were highly coregulated and not readily explained by postmortem interval, antipsychotic drug treatment, synaptosome yield, or underlying alterations in homogenate protein levels. CONCLUSIONS AND RELEVANCE: These findings suggest a robust and highly coordinated rearrangement of the synaptic proteome. In line with unbiased genetic findings, alterations in synaptic levels of postsynaptic proteins were identified, providing a road map to identify the specific cells and circuits that are impaired in individuals with schizophrenia A1.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. MacDonald ML, Garver M, Newman J, et al. Synaptic Proteome Alterations in the Primary Auditory Cortex of Individuals With Schizophrenia. JAMA Psychiatry. 2020. PMID: 31642882. doi:10.1001/jamapsychiatry.2019.2974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。